. Author manuscript; available in PMC: 2024 Jan 24.

Published in final edited form as: Aliment Pharmacol Ther. 2023 Nov 15;59(1):80–88. doi: 10.1111/apt.17783

TABLE 2.

Frequency of decompensation, HCC and death stratified by MEFIB and MRI-PDFF.

		MEFIB and MRI-PDFF
Total N = 296	Incident events (%)	MEFIB-negative, N = 193 (65%)	MEFIB+ and MRI-PDFF ≥5%, N = 79 (27%)	MEFIB+ and MRI-PDFF <5%, N = 24 (8%)
Decompensation, N (%)	22 (7)	0	14 (18)	8 (33)
Ascites	19 (6)	0	12 (15)	7 (29)
Hepatic encephalopathy	13 (4)	0	9 (11)	4 (17)
Variceal haemorrhage	3 (1)	0	1 (1)	2 (8)
Hepatocellular carcinoma, N (%)	15 (5)	1 (1)	10 (13)	4 (17)
Death, N (%)	17 (6)	3 (2)	10 (13)	4 (17)
Any of above^a, N (%)	32 (11)	4 (2)	18 (23)	10 (42)

Abbreviations: HCC, hepatocellular carcinoma; MEFIB, MRI combined with FIB-4; MRI-PDFF, magnetic resonance imaging-derived proton density fat fraction.

Patients with any of following—decompensation, HCC or death.